{
  "main_header": {
    "sid": 10039831,
    "name": "Rubicon Research",
    "stock_name": "Rubicon Research",
    "full_name": "Rubicon Research Ltd",
    "name_url": "stocks-analysis/rubicon-research",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "723.25",
    "chg": 35.15,
    "chgp": "5.11%",
    "dir": 1,
    "prev_price": "688.10",
    "mcapval": "11,647.00 Cr",
    "mcap": "",
    "scripcode": 544578,
    "symbol": "RUBICON",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE506V01022",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "3.77 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/rubicon-research-10039831-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 0,
    "sid": "10039831",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/rubicon-research-10039831"
  },
  "announcements": [
    {
      "caption": "Intimation Under Regulation 30 Read With Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "30-Jan-2026",
      "details": "Inspection/Search proceedings by GST Authorities",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "28-Jan-2026",
      "details": "Quarterly Earnings Conference Call to be held on Tuesday February 03 2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Will Be Held On Tuesday 03Rd February 2026 Inter-Alia To Consider And Approve The Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended 3",
      "datetime": "27-Jan-2026",
      "details": "Rubicon Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 inter alia to consider and approve The Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended 31St December 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

No Recent News for the Company

View All News